Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

MMP-9 and CD6'8 POT +' cells are required for tissue remodeling in response to natural hydroxyapatite (2009)

  • Authors:
  • USP affiliated authors: OLIVEIRA, RODRIGO CARDOSO DE - FOB ; TAGA, RUMIO - FOB
  • USP Schools: FOB; FOB
  • DOI: 10.1007/s10735-009-9241-2
  • Subjects: BIOMATERIAIS; IMPLANTE DE OSSO ORGÂNICO; HIDROXIAPATITA; METALOPROTEINASES; ANTÍGENOS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s10735-009-9241-2 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Journal of Molecular Histology

    ISSN: 1567-2379

    Citescore - 2017: 2.2

    SJR - 2017: 0.981

    SNIP - 2017: 0.77


  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ZAMBUZZI, Willian Fernando; PAIVA, Katiucia Batista Silva; MENEZES, Renato; et al. MMP-9 and CD6'8 POT +' cells are required for tissue remodeling in response to natural hydroxyapatite. Journal of Molecular Histology, Dordrecht, v. 40, n. 4, p. 301-309, 2009. Disponível em: < http://dx.doi.org/10.1007/s10735-009-9241-2 > DOI: 10.1007/s10735-009-9241-2.
    • APA

      Zambuzzi, W. F., Paiva, K. B. S., Menezes, R., Oliveira, R. C. de, Taga, R., & Granjeiro, J. M. (2009). MMP-9 and CD6'8 POT +' cells are required for tissue remodeling in response to natural hydroxyapatite. Journal of Molecular Histology, 40( 4), 301-309. doi:10.1007/s10735-009-9241-2
    • NLM

      Zambuzzi WF, Paiva KBS, Menezes R, Oliveira RC de, Taga R, Granjeiro JM. MMP-9 and CD6'8 POT +' cells are required for tissue remodeling in response to natural hydroxyapatite [Internet]. Journal of Molecular Histology. 2009 ; 40( 4): 301-309.Available from: http://dx.doi.org/10.1007/s10735-009-9241-2
    • Vancouver

      Zambuzzi WF, Paiva KBS, Menezes R, Oliveira RC de, Taga R, Granjeiro JM. MMP-9 and CD6'8 POT +' cells are required for tissue remodeling in response to natural hydroxyapatite [Internet]. Journal of Molecular Histology. 2009 ; 40( 4): 301-309.Available from: http://dx.doi.org/10.1007/s10735-009-9241-2

    Referências citadas na obra
    Accorsi-Mendonça T, Zambuzzi WF, Paiva KBS, Lauris JR, Cestari TM, Taga R, Granjeiro JM (2005) Expression of metalloproteinase 2 in the cell response to porous demineralized bovine bone matrix. J Mol Histol 36:311–316
    Accorsi-Mendonça T, Paiva KB, Zambuzzi WF, Cestari TM, Lara VS, Sogayar MC, Taga R, Granjeiro JM (2008a) Expression of matrix metalloproteinases-2 and -9 and RECK during alveolar bone regeneration in rat. J Mol Histol 39:201–208
    Accorsi-Mendonça T, Conz MB, Barros TC, Sena LA, Soares de GA, Granjeiro JM (2008b) Physicochemical characterization of two deproteinized bovine xenografts. Braz Oral Res 22:5–10
    Artzi Z, Tal H, Dayan D (2001) Porous bovine bone mineral in healing of human extraction sockets: 2. Histochemical observations at 9 months. J Periodontol 72:152–159
    Cestari TM, Granjeiro JM, de Assis GF, Garlet GP, Taga R (2009) Bone repair and augmentation using block of sintered bovine-derived anorganic bone graft in cranial bone defect model. Clin Oral Implants Res 20:340–350
    Coelho PG, Granjeiro JM, Romanos GE, Suzuki M, Silva NR, Cardaropoli G, Thompson VP, Lemons JE (2009) Basic research methods and current trends of dental implant surfaces. J Biomed Mater Res B Appl Biomater 88:579–596
    Corotti MV, Zambuzzi WF, Paiva KB, Menezes R, Pinto LC, Lara VS, Granjeiro JM (2009) Immunolocalization of matrix metalloproteinases-2 and -9 during apical periodontitis development. Arch Oral Biol 54:764–771
    Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387–2392
    Delaissé JM, Engsig MT, Everts V, del Carmen Ovejero M, Ferreras M, Lund L, Vu TH, Werb Z, Winding B, Lochter A, Karsdal MA, Troen T, Kirkegaard T, Lenhard T, Heegaard AM, Neff L, Baron R (2000) Foged NT (2000) Proteinases in bone resorption: obvious and less obvious roles. Clin Chim Acta. 291:223–234
    Dormán G, Kocsis-Szommer K, Spadoni C, Ferdinandy P (2007) MMP inhibitors in cardiac diseases: an update. Recent Pat Cardiovasc Drug Discov 2:186–194
    Elenitsas R, Schuchter LM (1998) The role of the pathologist in the diagnosis of melanoma. Curr Opin Oncol 10:162–169
    Garrett AP, Wenham RM, Sheets EE (2002) Monsel’s solution: a brief history. J Low Genit Tract Dis 6:225–227
    Gonçalves F, Granjeiro JM, Cestari TM, Taga R, Oliveira RC, Zanetti RV, Zanetti AL (2005) Ridge Augmentation by using xenogenic materials: case report. Implant News 2:491–497
    Hannas AR, Pereira JC, Granjeiro JM, Tjäderhane L (2007) The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 65:1–13
    Heikkilä P, Teronen O, Moilanen M, Konttinen YT, Hanemaaijer R, Laitinen M, Maisi P, van der Pluijm G, Bartlett JD, Salo T, Sorsa T (2002) Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines. Anti-Cancer Drug 13:245–254
    Keibel A, Singh V, Sharma MC (2009) Inflammation, microenvironment, and the immune system in cancer progression. Curr Pharm Des 15:1949–1955
    Kneser U, Schaefer DJ, Polykandriotis E, Horch RE (2006) Tissue engineering of bone: the reconstructive surgeon’s point of view. J Cell Mol Med 10:7–19
    Kunisch E, Fuhrmann R, Roth A, Winter R, Lungershausen W, Kinne RW (2004) Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 63(7):774–784
    Laquerrier P, Grandjean-Laquerrier A, Addadi-Rebbah S, Jallot E, Laurent-Maquin D, Frayssinet P, Guenounou M (2004) MMP-2, MMP-9 and their inhibitors TIMP-2 and TIMP-1 production by human monocytes in vitro in the presence of different forms of hydroxyapatite particles. Biomaterials 5:2515–2524
    Makowiski GS, Ramsby ML (2003) Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection. Clin Chim Acta 329:77–81
    McCawley LJ, Matrisian LM (2001) Matrix Metalloproteinases: they are not just for matrix anymore! Curr Opin Cell Biol 13:534–540
    Mellonig JT (1999) Human Histologic evaluation of a bovine-derived bone xenograft in the treatment of periodontal osseous defects. Int J Periodontics Restorative Dent 20:19–29
    Menezes R, Bramante CM, Silva Paiva KB, Letra A, Carneiro E, Fernando Zambuzzi W, Granjeiro JM (2006) Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:404–409
    Morgan MP, Cooke MM, Christopherson PA, Westfall PR, McCarthy GM (2001) Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines. Mol Carcinog 32:111–117
    Muroski ME, Roycik MD, Newcomer RG, Van den Steen PE, Opdenakker G, Monroe HR, Sahab ZJ, Sang QX (2008) Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr Pharm Biotechnol 9:34–46
    Nakata H, Ohtsuki T, Sisido M (2009) A protease inhibitor discovery method using fluorescence correlation spectroscopy with position-specific labeled protein substrates. Anal Biochem 390:121–125
    Nickoloff BJ, Griffiths CE (1989) The spindle-shaped cells in cutaneous Kaposi’s sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes. Am J Pathol 135:793–800
    Oliveira RC, Menezes R, Cestari TM, Taga EM, Taga R, Buzalaf MAR, Granjeiro JM (2004) Tissue response to a membrane of demineralized bovine cortical bone implanted in the subcutaneous tissue of rats. Braz Dent J 15:3–8
    Oliveira RC, Carneiro E, Cestari TM, Taga R, Granjeiro JM (2006) Dynamics of subcutaneous tissue response to the implantation of tetracycline-treated or untreated membrane of demineralized bovine cortical bone in rats. J Biomater Appl 21:167–178
    Paiva KB, Zambuzzi WF, Accorsi-Mendonça T, Taga R, Nunes FD, Sogayar MC, Granjeiro JM (2009) Rat forming incisor requires a rigorous ECM remodeling modulated by MMP/RECK balance. J Mol Histol 40:201–207
    Pilling D, Fan T, Huang D, Kaul B, Gomer RH (2009) Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 4:e7475
    Rittenberg B, Partridge E, Baker G, Clokie C, Zohar R, Dennis JW, Tenenbaum HC (2005) Regulation of BMP-induced ectopic bone formation by Ahsg. J Orthop Res 23:653–662
    Stavropoulos A, Kostopoulos L, Nyengaard JR, Karring T (2003) Deproteinized bovine bone (Bio-Oss) and bioactive glass (Biogran) arrest bone formation when used as an adjunct to guided tissue regeneration (GTR): an experimental study in the rat. J Clin Periodontol 30:636–643
    Urist MR (1970) Quantitation of new bone formation in intramuscular implants of bone matrix in babbits. Clin Orthop 68:279–293
    Valleala H, Hanemaaijer R, Mandelin J, Salminen A, Teronen O, Mönkkönen J, Konttinen YT (2003) Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates. Life Sci 73:2413–2420
    van Heest A, Swiontkowski M (1999) Bone-Graft Substitutes. Lancet 353:28–29
    Vasikaran SD (2001) Bisphosphonates: an overview with special reference to alendronate. Ann Clin Biochem 38:608–623
    Welker P, Grabbe J, Zuberbier T, Guhl S, Henz BM (2000) Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. J Invest Dermatol 114(1):44–50
    Woessner JF, Nagase H (2000) Matrix Metalloproteinases and TIMPs. Oxford Univ Press, New York
    Zambuzzi WF, Oliveira RC, Alanis D, Menezes R, Letra A, Cestari TM, Taga R, Granjeiro JM (2005) Tissue response to porous microgranular bovine inorganic bone implanted in rat subcutaneous tissue. J Appl Oral Sci 13:382–386
    Zambuzzi WF, Oliveira RC, Pereira FL, Cestari TM, Taga R, Granjeiro JM (2006a) Rat subcutaneous tissue response to macrogranular porous anorganic bovine bone graft. Braz Dent J 17:274–278
    Zambuzzi WF, Oliveira RC, Piozzi R, Cestari TM, Taga R, Buzalaf MAR, Granjeiro JM (2006b) Histological evaluation of acellular and demineralized fetal bovine bone in the subcutaneous of rats. Rev Bras Ortop 41:227–232
    Zambuzzi WF, Yano CL, Cavagis AD, Peppelenbosch MP, Granjeiro JM, Ferreira CV (2009a) Ascorbate-induced osteoblast differentiation recruits distinct MMP-inhibitors: RECK and TIMP-2. Mol Cell Biochem 322:143–150
    Zambuzzi WF, Paiva KB, Batista AC, Lara VS, Granjeiro JM (2009b) Immunohistochemical approach reveals involvement of inducible nitric oxide synthase in rat late development. J Mol Histol 40:235–240